Expertise in
3
conditions

Mary M. Mccormack

London, ENG, GB 
Expertise in
3
conditions
London, ENG, GB 

Overview

Mary Mccormack practices practicing medicine in London, United Kingdom.

Ms. Mccormack is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Endometrial Cancer, Ovarian Cancer, and Lymphadenectomy.

She is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

London, ENG NW12BU, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Multicentre Trial of Weekly Induction Chemotherapy Followed by Standard Chemoradiation Versus Standard Chemoradiation Alone in Patients With Locally Advanced Cervical Cancer
A Phase III Multicentre Trial of Weekly Induction Chemotherapy Followed by Standard Chemoradiation Versus Standard Chemoradiation Alone in Patients With Locally Advanced Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 05, 2024
Intervention Type: Radiation, Drug
Study Drugs: Paclitaxel, Carboplatin, Cisplatin
Study Phase: Phase 3

49 Total Publications

Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Journal: Obstetrical & gynecological survey
Published: October 30, 2025

Frequently Asked Questions about Mary M. Mccormack

Is Mary M. Mccormack a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Mary M. Mccormack is classified as an Distinguished expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mary M. Mccormack participate in research or clinical trials?

Yes. Mary M. Mccormack has published 49 articles and abstracts on conditions like Cervical Cancer. You can view a list of Mary M. Mccormack's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mccormack's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile